Risk of severe life threatening asthma and β agonist type: An example of confounding by severity

Thorax

Volumn 51, Issue 11, 1996, Pages 1093-1099

  Garrett, J E ^a   Lanes, S F ^b   Kolbe, J ^a   Rea, H H ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

^b Epidemiology Resources Inc   (United States)

Author keywords

Confounding by severity; Fenoterol; Severe life threatening asthma

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FENOTEROL; IPRATROPIUM BROMIDE; SALBUTAMOL; THEOPHYLLINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; COHORT ANALYSIS; DISEASE SEVERITY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0029845475     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.11.1093     Document Type: Article

References (23)

1. Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet 1989; i:917-22.
2. Rea HH. Fenoterol and fatal asthma (letter). NZ Med J 1989;302:356-7.
3. Grainger J, Woodman K, Pearce N, Crane J, Burgess C, Keane A, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax 1991;46:105-11.
4. Pearce N, Crane J, Beasley R, Burgess C, Jackson R. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study (letter). Thorax 1992; 47:574.
5. Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, Cockroft D, et al. A cohort analysis of excess mortality in asthma and the use of β-agonists. Am J Respir Crit Care Med 1994;149:604-10.
6. Lanes SF, Poole C, Walker A. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study (letter). Thorax 1992;47:574.
7. Brenner H. Bias due to non-differential misclassification of polytomous confounders. J Clin Epidemiol 1993;46:57-63.
8. Garrett J. Baseline risk for asthma death (letter). NZ Med J 1992;105:319.
9. Pearce N, Grainger J, Atkinson M, Crane J, Burgess C, Windom H, et al. Case control study of prescribed fenoterol and death from asthma in New Zealand 1977-81. Thorax 1990;45:170-5.
10. Burgess C, Pearce N, Thiruchelvan R, Wilkinson R, Linaker C, Woodman K, et al. Prescribed drug therapy and near-fatal asthma attacks. Eur Respir J 1994;7:498-503.
11. Richards GN, Kolbe J, Fenwick J, Rea HH. Demographic characteristics of patients with severe life threatening asthma: a comparison with asthma deaths. Thorax 1993; 48:1105-9.
12. Rothman KJ. Modern epidemiology. Boston: Little, Brown and Company, 1986:64.
13. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Publ Health 1989;79:340-9.
14. Garrett JE, Mulder J, Wong-Toi H. Reasons for racial differences in A&E attendance rates for asthma. NZ Med J 1989;102:121-4.
15. Garrett JE, Mulder J, Wong Toi H. Characteristics of asthmatics using an urban accident and emergency department. NZ Med 1988;101:359-61.
16. Spitzer WO, Suissa S, Ernst P, Horwitz R, Habbick B, Cockroft D, et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326:501-6.
17. Petri H, Urquhart J, Herings R, Bakker A. Characteristics of patients prescribed three different inhalational beta-2 agonists: an example of the channeling phenomenon. Post Marketing Surveillance 1991;5:57-66.
18. Garrett JE, Turner P. The severity of asthma in relation to β-agonist prescribing. NZ Med 1991;104:39-40.
19. Wilson JD. Selective prescribing of fenoterol and salbutamol in New Zealand general practice. Post Marketing Surveillance 1991;5:105-8.
20. Crane J, Burgess C, Pearce N, Beasley R. The β-agonist controversy: a perspective. Eur Respir Rev 1993;3:475-82.
21. Rea HH, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland DC. Case control study of asthma deaths. Thorax 1986;41:833-9.
22. Kolbe J, Vamos M, Richards G, Garrett J. Differences in asthma self management knowledge and behaviour in acute severe asthma. Chest 1996 (in press).
23. Beasley R, Burgess C, Pearce N, Woodman K, Crane J. Confounding by severity does not explain the association between fenoterol and asthma death. Clin Exp Allergy 1994;24:660-8.